Back
Regeneron Pharmaceuticals Stock Predictions
While Jobs Disappear, Phones Are Picking Up The Slack
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
$666.68
Seasonality Move:
3.9%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31.8% based on the past 33 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $666.87. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31.8% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
642.00
Prediction Charts
Market Cap:
72.9B
Price in USD:
666.87
Volume:
1.3M
Beta:
0.95
Technical Analysis
SMA50:
695.18
SMA100:
751.87
SMA200:
914.97
52-Wk Change:
-30.46%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 666.87 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-21 | 697.93 | 700.33 | 704.08 | 693.07 |
| Feb-25 | 720.00 | 723.47 | 739.00 | 715.50 |
| Feb-26 | 721.29 | 706.94 | 721.41 | 701.07 |
| Feb-27 | 705.90 | 702.78 | 721.00 | 700.67 |
| Feb-28 | 701.32 | 698.74 | 708.58 | 693.71 |
| Mar-3 | 701.91 | 684.87 | 704.64 | 683.46 |
| Mar-4 | 688.48 | 675.49 | 697.46 | 672.50 |
| Mar-5 | 673.98 | 687.15 | 692.79 | 673.15 |
| Mar-6 | 683.10 | 698.44 | 701.00 | 682.26 |
| Mar-7 | 698.63 | 707.51 | 729.75 | 696.43 |
| Mar-11 | 746.70 | 718.16 | 747.70 | 712.39 |
| Mar-12 | 709.94 | 689.50 | 712.46 | 683.43 |
| Mar-13 | 687.43 | 680.61 | 698.95 | 677.34 |
| Mar-14 | 680.61 | 666.87 | 686.98 | 657.00 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.82 per share, a decrease next quarter of $0.32 per share, a decrease this year of $2.09 per share, and an increase next year of $4.20 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.